Navigation Links
Worldwide Medical Polymer Markets: 2013-2020
Date:11/13/2013

London (PRWEB) November 13, 2013

SUMMARY

NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the aging of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elder patients.

Opportunity in this market has also expanded because the latest technical developments in medical polymers can fine tune implant capabilities, enable better fits for implants, and increased biocompatibility. Polymer structures can also now substitute for cartilage or enable doctors to grow a patient’s tissue for transplants.

At the same time the new legal protections that followed the silicone breast implant debacle have considerably reduced the risk in the medical polymer space. And as a result of all of these factors, the medical polymer business has taken off, with the emergence of new start ups and plenty of M&A activity.

With all that is happening in this space, NanoMarkets is publishing a report that identifies current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising. As with all NanoMarkets reports in the medical materials field, this report includes a granular eight-year forecast and also profiles key suppliers and analyzes the complete supply chain for medical polymers. For the firms covered we discuss their strategies and needs along with their strengths and weaknesses. Finally, the report provides an analysis of the market for medical polymers in various important country-specific markets.

Readers of this report will gain the following:

•An analytical review of polymers used for medical applications, including developing implants, diagnostic systems, and hospital labware.
•Knowledge on current technical and market trends, including general market drivers for improvement in the healthcare sector, polymer production, and evaluation for clinical approval.
•An understanding of key medical products and their future implications.
•A pin-pointed analysis of the changing dynamics of polymer producers.
•Eight–year forecasts based on expected market growth.
•A brief technological road map for understanding industry growth.
•Profiles of major companies operating as manufacturers of medical polymers.
•Insight into important geographical locations pertaining to polymer and healthcare sectors.
•Information on the size of the medical polymer market in developed nations and the fast-growing economies in Asia, such as China and India.
•Details of the regulatory requirements of these countries for producing high-quality, medically approved polymers and their use in various applications.
•Help in making business decisions for venturing into the medical polymer market.
•Descriptive and distinctive graphics, along with concise, tabular analyses of various domains
Executive Summary

E.1 Opportunities in the Medical Device Market
E.2 Opportunities for the Plastics Industry
E.3 Firms and Strategies to Watch in the Medical Polymer Market
E.3.1 Bayer MaterialScience
E.3.2 Celanese
E.3.3 Dow Corning
E.3.4 Dow Chemical
E.3.5 DSM
E.3.6 DuPont
E.3.7 Eastman Chemical
E.3.8 Evonik
E.3.9 Solvay
E.4 Summary of Eight-Year Forecasts of the Medical Polymer Market

Chapter One: Introduction

1.1 Background to this Report
1.1.1 Boom in Thermoplastic Elastomers (TPES) and Engineered Plastics (Super Specialty Plastics)
1.1.2 Rise of Degradable Polymers
1.1.3 Important Points for Manufacturers
1.2 Scope and Objectives of this Report
1.3 Methodology and Information Sources
1.4 Plan of this Report

Chapter Two: Commercial Trends in Medical Polymers

2.1 Generic Advantages and Disadvantages of Polymers for Medical Applications
2.1.1 Advantages of Polymers in Medical Applications
2.1.2 Disadvantages of Polymers in Medical Applications
2.1.3 Replacement of Metals with Polymers in Medical Devices
2.2 Thermoplastics (PMMA, PLA, PGA, PP, PEEK, Polycarbonates)
2.2.1 Uses of Thermoplastics in Medical Applications
2.2.2 Main Suppliers of Thermoplastics for Medical Applications
2.3 Polyethylene (PE)
2.3.1 Uses of PE in Medical Applications
2.3.2 Main Suppliers of PE for Medical Applications
2.4 Polystyrene
2.4.1 Uses of Polystyrene and Styrenics in Medical Applications
2.4.2 Main Suppliers of PS for Medical Applications
2.5 Polyvinyl Chloride
2.5.1 Uses of PVC in Medical Applications
2.5.2 Main Suppliers of PVC for Medical Applications
2.6 Nylon
2.6.1 Uses of Nylon in Medical Applications
2.6.2 Main Suppliers of Nylon for Medical Applications
2.7 Other Polymers for Medical Applications
2.8 Role of Bioplastics in Medical Applications
2.9 Key Points from this Chapter

Chapter Three: Applications for Medical Polymers

3.1 Pricing and Forecast Assumptions
3.1.1 Explanation of Polymer Pricing
3.1.2 Use of Medical Polymers in Different Applications
3.2 Medical Devices and Implants
3.2.1 Current and Future Use of Polymers
3.2.2 Regenerative Medicine and Orthopedic Implants
3.2.3 Contact Lenses and Lens Implants
3.2.4 Implantable Defibrillators and Related Devices
3.2.5 Breast Implants
3.2.6 Conductive Polymer Neural Implants
3.2.7 Blood Filters
3.2.8 Other Medical Devices Using Polymers
3.3 Eight-Year Forecast of Polymers in Implants by Polymer and Implant Type
3.4 Eight-Year Forecast of Polymers in Non-Implantable Devices by Polymer and Device Type
3.4.1 Diagnostic Systems
3.5 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.5.1 Laboratory and Surgical Accessories and Disposables
3.5.2 Surgical Screws, Nails and Plates
3.5.3 Catheters and Tubing
3.5.4 Surgical Gloves
3.5.5 Sutures and Shunts
3.6 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.7 Summary of Forecasts of Medical Polymers
3.7.1 Summary Forecast of Medical Polymers by Application
3.8 Summary Forecast of Medical Polymers by Polymer Type
3.9 Key Points in this Chapter

Chapter Four: National Markets and Regulatory Factors

4.1 Generic Policy Issues Raised by Polymer Medical Devices
4.1.1 Safety Issues Related to Polymer Devices
4.1.2 Problems of Waste Disposal and Management in Medical Polymer Manufacturing
4.1.3 Healthcare Issues and an Aging Population
4.1.4 Geographical Distribution of the Markets
4.2 The Medical Polymer Market in the United States
4.2.1 Medical Polymers and the Biomaterials Access Assurance Act of 1998
4.2.2 Impact of “Obamacare”
4.2.3 Role and Impact of the FDA
4.2.4 Analysis of the Market for Medical Polymers in the U.S.
4.2.5 Eight-Year Forecasts for Medical Polymers in the U.S.
4.3 The Medical Polymer Market in Europe
4.3.1 Role and Impact of the European Commission and Other Regulatory Authorities in the European Union
4.3.2 National Regulations and Regulatory Agencies Impacting Medical Polymer Markets in the EU
4.3.3 Analysis of the Market for Medical Polymers in Europe
4.3.4 Eight-Year Forecast for Medical Polymers in Europe
4.4 The Medical Polymer Market in Japan
4.4.1 National Laws and Regulations Impacting the Medical Polymer Market in Japan
4.4.2 Analysis of Market for Medical Polymers in Japan
4.4.3 Eight-Year Forecast for Medical Polymers in Japan
4.5 The Medical Polymer Market in China
4.5.1 National Laws and Regulations Impacting the Medical Polymer Market in China
4.5.2 Impact of Chinese Industrial Policy on the Medical Polymer Market
4.5.3 Analysis of the Market for Medical Polymers in China
4.5.4 Eight-Year Forecast for Medical Polymers in China
4.6 The Medical Polymer Market in India
4.6.1 National Laws and Regulations Impacting the Medical Polymer Market in India
4.6.2 Analysis of the Market for Medical Polymers in India
4.6.3 Eight-Year Forecast for Medical Polymers in India
4.7 Other Notable National Markets for Medical Polymers
4.7.1 The Medical Polymer Market in Canada
4.7.2 The Medical Polymer Market in Australia
4.7.3 The Medical Polymer Market in South Korea
4.8 Summary of Eight-Year Forecasts of Medical Polymers by Country
Acronyms and Abbreviations Used In this Report
About the Author

List of Exhibits

Exhibit E-1: Summary Forecast of Medical Polymers by Application ( US$ Millions)
Exhibit 2-1: Important Advantages of Polymers and Their Current Applications
Exhibit 2-2: Thermoplastics - Properties and Uses
Exhibit 2-3: Common Suppliers of Thermoplastics
Exhibit 2-4: Opportunities for Different PE Grades
Exhibit 2-5: Different Suppliers of Polyethylene Products and their Features
Exhibit 2-6: Requirements and Medical Applications for Various Types of PS
Exhibit 2-7: Suppliers Of GPPS, HIPS, and SPS Products for Medical Applications and their Trade Names
Exhibit 2-8: Suppliers and Characteristics of Flexible, Rigid and Semi-rigid Medical Grades of PVC
Exhibit 2-9: Nylon Products and Manufacturers
Exhibit 2-10: Medical Devices and Implants Made from Polyurethanes
Exhibit 2-11: Leading Teflon products, Their Manufacturers, and Application Areas
Exhibit 3-1: Pricing of Polymers and Polymer-Based Medical Products
Exhibit 3-2: Approximate Market Share of Different Polymer Types in Each Application
Exhibit 3-3: Selected Polymeric Orthopedic Products, their Manufacturers and Opportunities
Exhibit 3-4: Approved Breast Implants and their Market Opportunities
Exhibit 3-5: Overview of Important Blood Filters
Exhibit 3-6: Overview of Selected Wound Dressing Materials
Exhibit 3-7: Orthopedic Implants and Regenerative Medicines Forecast
Exhibit 3-8: Forecast of Polymer Use In Lens Implants
Exhibit 3-9: Forecast of Polymer Use in Contact Lenses
Exhibit 3-10: Forecast of Polymer Use in Implantable Defibrillators
Exhibit 3-11: Forecast of Polymer Use In Breast Implants
Exhibit 3-12: Forecast of Conductive Polymer Use In Neural Implants
Exhibit 3-13: Forecast of Polymer Use In Blood Filters
Exhibit 3-14: Forecast of Polymer Use In Other Medical Devices
Exhibit 3-15: Polymers Used in Diagnostic Devices and Their Future Opportunities
Exhibit 3-16: Forecast of Polymer Use In Diagnostic Devices
Exhibit 3-17: Forecast of Polymer Use In Automated Analyzers
Exhibit 3-18: Forecast of Polymer Use In Homecare Diagnostic Devices
Exhibit 3-19: Forecast of Polymer Use In Point-of-Care (POC) Diagnostics
Exhibit 3-20: Overview of Important Polymers for Multiple-Use and Disposable Labware Fabrication
Exhibit 3-21: Leading Labware Manufacturers and Their Brands and Market Potential
Exhibit 3-22: Selected Catheter and Tubing Products
Exhibit 3-23: Surgical Gloves and Their Specifications
Exhibit 3-24: Forecast of Polymer Use In Surgical Screws, Nails and Plates
Exhibit 3-25: Forecast of Polymer Use In Catheters and Tubing
Exhibit 3-26: Forecast of Polymer Use In Surgical Gloves
Exhibit 3-27: Forecast of Polymer Use In Sutures and Shunts
Exhibit 3-28: Summary Forecast of Medical Polymers by Application (US $Millions)
Exhibit 3-29: Summary Forecast by Top Polymer Types (U.S.$ Millions)
Exhibit 4-1: Key Industry Issues, Their Impacts, and Probable Solutions
Exhibit 4-2: Important U.S. Regulations Affecting Medical Polymers
Exhibit 4-3: Key Players in the U.S. Medical Polymer Industry Responding to Major Trends
Exhibit 4-4: Eight-Year Forecast of Medical Polymers in the U.S. (US$ Millions)
Exhibit 4-5: Key EC Regulations and Their Significance
Exhibit 4-6: Recent Technology Developments in Europe
Exhibit 4-7: Eight-Year Forecast for Medical Polymers in Europe (US$ Millions)
Exhibit 4-8: Important Regulations in Japan and Their Impact on the Medical Polymers Market
Exhibit 4-9: Recent Technology Developments in Japan
Exhibit 4-10: Eight-Year Forecast for Medical Polymers in Japan (US $Millions)
Exhibit 4-11: Key Impacts of CFDA Policies and Opportunities for Policy Improvement in China
Exhibit 4-12: Recent Technology Developments in China
Exhibit 4-13: Eight-Year Forecast for Medical Polymers in China (US $Millions)
Exhibit 4-14: Key Regulatory Impacts and Opportunities for Policy Improvement in India
Exhibit 4-15: Recent Technology Developments in India
Exhibit 4-16: Eight-Year Forecast for Medical Polymers in India (US $Millions)
Exhibit 4-17: Regulatory Scenario and Industry Opportunities in Other Markets
Exhibit 4-18: Global Eight-Year Forecast for Medical Polymers Broken Out by Country/Region

Read the full report:

Worldwide Medical Polymer Markets: 2013-2020

http://www.reportbuyer.com/chemicals/plastics/worldwide_medical_polymer_markets_2013_2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Read the full story at http://www.prweb.com/releases/2013/11/prweb11330108.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dental Care Market in China 2012-2016: Worldwide Latest Market Share, Investment Trends, Growth, Size, Strategy And Forecast Research
2. Global Blood Collection Systems Market 2012-2016: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2016
3. Portable Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018
4. White Paper Predicts Less Snow More Rain Worldwide in Middle Latitudes
5. Wood Casket Promotion Just Launched By MillionaireCasket.com For Casket Wholesalers Worldwide
6. Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018
7. Global Compression Therapy Market 2012-2016: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy And Forecast Research Report
8. Type 2 Diabetes Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019: Worldwide Industry Latest Market Report
9. Smokers worldwide more likely to think about kicking their habit on Mondays
10. New NanoMarkets Report States That The Worldwide Medical Ceramics Market Will Grow from $1.1 Billion in 2013 to $2.3 Billion in 2018
11. Cataleng Announces New Optimized Drug Delivery Technologies at CPhl Worldwide/ICSE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... In an article ... divorcee, shares her enthusiasm for Botox and lip injections, which she underwent in order ... oriented Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for ... and mood optimization products to the store is just one more way Shamangelic ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American workforce ... stability, even security. Most importantly, employees are the single most important asset in ... workers so unhappy? , Just under half of American workers are emotionally checked ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Conditions were ideal ... Cove Island Park on Sunday, with sunny skies, a light breeze and temperatures in ... $33,000. , The 5k Run and Walk and 1-mile walk were held ...
(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment ... been invited to be a featured speaker at the Texas Society of the American ... 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- Treato , the single largest ... that it has been named a Cool Vendor by ... Sciences, 2016, Stephen Davies , Michael ... life-science- oriented analytics, algorithms and smart machine technology in ... medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... MARLBOROUGH, Mass., April 27, 2016  Hologic, Inc. ... Company,s financial results for the fiscal second quarter ... share (EPS) of $0.24 increased 41.2%, and non-GAAP ... $693.3 million increased 5.8% on a reported basis, ... "We posted another good quarter, highlighted ...
Breaking Medicine Technology: